May 02, 2018
Targovax announces early signal of efficacy in ONCOS-102 trial in mesothelioma
Media
May 02, 2018
Q1 2018 General Market Overview
April 27, 2018
Wilson Therapeutics’ 2017 Annual Report published
April 26, 2018
Strongbridge Biopharma plc to Host First Quarter 2018 Financial Results Conference Call on May 10, 2018
April 24, 2018
Targovax ASA: Invitation to first quarter 2018 results presentation Thursday 3 May
April 24, 2018
Onxeo Announces Initiation of DRIIV Phase I Clinical Trial of AsiDNA™ for Treatment of Advanced Solid Tumor
April 23, 2018
MIPS receives a positive decision in European patent case
April 20, 2018
Nexstim Plc to present at BioTrinity 2018 in London
April 19, 2018
MIPS and POC Sweden have reached a settlement and will strengthen their cooperation
April 16, 2018
Aprea Therapeutics Presents Results From Phase Ib/II Clinical Study of APR-246 and Azacitidine (AZA) in Patients with TP53 Mutant Myelodysplastic Syndromes (MDS) at the 2018 American Association of Cancer Research (AACR) Annual Meeting in Chicago
